What is the current valuation of the US glaucoma surgery market?

The US glaucoma surgery market was valued at approximately 178.85 USD Million in 2024. Read More

What is the projected market size for the US glaucoma surgery market by 2035?

The market is expected to reach a valuation of 343.0 USD Million by 2035. Read More

What is the expected CAGR for the US glaucoma surgery market during the forecast period?

The expected CAGR for the US glaucoma surgery market from 2025 to 2035 is 6.1%. Read More

Which companies are considered key players in the US glaucoma surgery market?

Key players include Alcon, AbbVie, Bausch + Lomb, Glaukos, Carl Zeiss, Santen, Johnson & Johnson, Merck, and Novartis. Read More

What are the primary types of surgeries performed in the US glaucoma surgery market?

The primary types of surgeries include Trabeculectomy, Tube Shunt Surgery, Minimally Invasive Glaucoma Surgery, Laser Surgery, and Cataract Surgery with Glaucoma Treatment. Read More

How does patient demographics influence the US glaucoma surgery market?

Patient demographics, including age, gender, ethnicity, socioeconomic status, and insurance coverage, significantly impact market dynamics, with insurance coverage valued between 68.85 and 123.0 USD Million. Read More

What surgical techniques are utilized in the US glaucoma surgery market?

Surgical techniques encompass Traditional Surgery, Endoscopic Surgery, Robotic Surgery, Laser-Assisted Surgery, and Combined Surgery, with Traditional Surgery valued between 60.0 and 120.0 USD Million. Read More

What postoperative care services are available in the US glaucoma surgery market?

Postoperative care services include Follow-Up Visits, Medication Management, Rehabilitation Services, Patient Education, and Complications Management, with Medication Management valued between 45.0 and 90.0 USD Million. Read More

What market dynamics are shaping the US glaucoma surgery market?

Market dynamics are influenced by the Regulatory Environment, Technological Advancements, Market Trends, Competitive Landscape, and Patient Awareness, with Technological Advancements valued between 40.0 and 80.0 USD Million. Read More

How does the competitive landscape affect the US glaucoma surgery market?

The competitive landscape is characterized by the presence of major players like Johnson & Johnson and Merck, which may drive innovation and market growth. Read More

US Glaucoma Surgery Market

ID: MRFR/MED/17433-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Glaucoma Surgery Market Research Report By Target (Trabecular meshwork, Suprachoroidal space, Others), By Type of surgery (Angle closure glaucoma surgery, Aqueous shunt surgery, laser surgery, Others) and By End User (Hospital, Ambulatory surgery centers, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Surgery Type (USD Million)
  1. 4.1.1 Trabeculectomy
  2. 4.1.2 Tube Shunt Surgery
  3. 4.1.3 Minimally Invasive Glaucoma Surgery
  4. 4.1.4 Laser Surgery
  5. 4.1.5 Cataract Surgery with Glaucoma Treatment
2. 4.2 Healthcare, BY Patient Demographics (USD Million)
  1. 4.2.1 Age Group
  2. 4.2.2 Gender
  3. 4.2.3 Ethnicity
  4. 4.2.4 Socioeconomic Status
  5. 4.2.5 Insurance Coverage
3. 4.3 Healthcare, BY Surgical Technique (USD Million)
  1. 4.3.1 Traditional Surgery
  2. 4.3.2 Endoscopic Surgery
  3. 4.3.3 Robotic Surgery
  4. 4.3.4 Laser-Assisted Surgery
  5. 4.3.5 Combined Surgery
4. 4.4 Healthcare, BY Postoperative Care (USD Million)
  1. 4.4.1 Follow-Up Visits
  2. 4.4.2 Medication Management
  3. 4.4.3 Rehabilitation Services
  4. 4.4.4 Patient Education
  5. 4.4.5 Complications Management
5. 4.5 Healthcare, BY Market Dynamics (USD Million)
  1. 4.5.1 Regulatory Environment
  2. 4.5.2 Technological Advancements
  3. 4.5.3 Market Trends
  4. 4.5.4 Competitive Landscape
  5. 4.5.5 Patient Awareness
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Alcon (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 AbbVie (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bausch + Lomb (CA)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Glaukos (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Carl Zeiss (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Santen (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Johnson & Johnson (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Merck (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Novartis (CH)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY SURGERY TYPE
3. 6.3 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
4. 6.4 US MARKET ANALYSIS BY SURGICAL TECHNIQUE
5. 6.5 US MARKET ANALYSIS BY POSTOPERATIVE CARE
6. 6.6 US MARKET ANALYSIS BY MARKET DYNAMICS
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY SURGERY TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY SURGERY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY POSTOPERATIVE CARE, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY MARKET DYNAMICS, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY MARKET DYNAMICS, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SURGERY TYPE, 2026-2035 (USD Million)
  2. 7.2.2 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
  3. 7.2.3 BY SURGICAL TECHNIQUE, 2026-2035 (USD Million)
  4. 7.2.4 BY POSTOPERATIVE CARE, 2026-2035 (USD Million)
  5. 7.2.5 BY MARKET DYNAMICS, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Surgery Type (USD Million, 2026-2035)

Trabeculectomy
Tube Shunt Surgery
Minimally Invasive Glaucoma Surgery
Laser Surgery
Cataract Surgery with Glaucoma Treatment

Healthcare By Patient Demographics (USD Million, 2026-2035)

Age Group
Gender
Ethnicity
Socioeconomic Status
Insurance Coverage

Healthcare By Surgical Technique (USD Million, 2026-2035)

Traditional Surgery
Endoscopic Surgery
Robotic Surgery
Laser-Assisted Surgery
Combined Surgery

Healthcare By Postoperative Care (USD Million, 2026-2035)

Follow-Up Visits
Medication Management
Rehabilitation Services
Patient Education
Complications Management

Healthcare By Market Dynamics (USD Million, 2026-2035)

Regulatory Environment
Technological Advancements
Market Trends
Competitive Landscape
Patient Awareness

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”